Penetration and clearance of cefoperazone and moxalactam in pleural fluid
- PMID: 3985598
- PMCID: PMC176211
- DOI: 10.1128/AAC.27.1.93
Penetration and clearance of cefoperazone and moxalactam in pleural fluid
Abstract
The penetration of cefoperazone and moxalactam into pleural fluid was studied in 11 patients after intravenous infusion of 2-g doses of these agents. Clearance of these agents from pleural fluid was studied in seven patients after instillation of 1-g doses into the pleural space. The concentrations in pleural fluid after intravenous infusion of 2-g doses reached a peak of 7 to 25 micrograms/ml for cefoperazone and 9 to 35 micrograms/ml for moxalactam at 4 to 6 h after administration. These levels exceeded reported MICs for most susceptible organisms. The elimination half-life of both agents was about two to five times longer in pleural fluid than in serum. These prolonged elimination rates of both agents might be of great advantage for killing bacteria in the pleural space.
Similar articles
-
[A clinical study of cefoperazone in surgery. Prevention of postoperative infections and transfer into pleural effusion].Jpn J Antibiot. 1985 Jun;38(6):1654-60. Jpn J Antibiot. 1985. PMID: 4046179 Japanese.
-
[Clinical experience with cefoperazone in respiratory tract infections and studies on its penetration into pleural effusion].Jpn J Antibiot. 1983 Dec;36(12):3456-62. Jpn J Antibiot. 1983. PMID: 6674553 Japanese.
-
Comparative pharmacokinetics of moxalactam, cefoperazone, and cefotaxime in normal volunteers.Rev Infect Dis. 1982 Nov-Dec;4 Suppl:S585-94. doi: 10.1093/clinids/4.supplement_3.s585. Rev Infect Dis. 1982. PMID: 6296967
-
Comparison of N-methylthiotetrazole dispositions in healthy volunteers following single intravenous doses of moxalactam, cefoperazone, and cefotetan.Antimicrob Agents Chemother. 1989 Jun;33(6):857-61. doi: 10.1128/AAC.33.6.857. Antimicrob Agents Chemother. 1989. PMID: 2764537 Free PMC article. Clinical Trial.
-
A review and summary of the pharmacokinetics of cefoperazone: a new, extended-spectrum beta-lactam antibiotic.Ther Drug Monit. 1981;3(2):121-8. doi: 10.1097/00007691-198102000-00002. Ther Drug Monit. 1981. PMID: 6455787 Review.
Cited by
-
Penetration of amphotericin B lipid formulations into pleural effusion.Antimicrob Agents Chemother. 2007 Nov;51(11):4211-3. doi: 10.1128/AAC.01087-07. Epub 2007 Sep 4. Antimicrob Agents Chemother. 2007. PMID: 17785511 Free PMC article. Clinical Trial.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources